Merck, Organon Must Face Warning, Warranty Claims in Calif. Federal Singulair Action

  • Order

SAN DIEGO — A California federal judge has refused to dismiss an action targeting Singulair (montelukast), ruling the plaintiffs adequately alleged they ingested the asthma drug and that the defendant drug makers failed to adequately warn it can cause anxiety and suicidal thoughts.

In a Sept. 8 order, Judge Marilyn Huff of the U.S. District Court for the Southern District of California further found the plaintiffs sufficiently alleged Merck and its subsidiary Organon & Co. breached their warranties that Singulair is safe and effective and would not result in neuropsychiatric side effects.

Singulair is prescribed for the treatment of asthma, …


HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022


HarrisMartin's MDL Conference: Navigating Current Mass Tort Litigation

November 30, 2022 - New York, NY
The Knickerbocker